BA
XRAY icon

Bridgewater Associates’s Dentsply Sirona XRAY Stock Holding History

Bridgewater Associates’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-476,608
Closed -$5.45M – 1245
2025
Q4 		$5.45M Buy
476,608
+26,186
+6% +$307K 0.02% 505
2025
Q3 		$5.72M Buy
450,422
+360,295
+400% +$5.23M 0.02% 467
2025
Q2 		$1.43M Buy
+90,127
New +$1.35M 0.01% 444
2025
Q1 		– Sell
-225,523
Closed -$4.28M – 809
2024
Q4 		$4.28M Buy
225,523
+44,171
+24% +$934K 0.02% 363
2024
Q3 		$4.91M Sell
181,352
-120,669
-40% -$3.08M 0.03% 375
2024
Q2 		$7.52M Buy
302,021
+38,082
+14% +$1.09M 0.04% 292
2024
Q1 		$8.76M Sell
263,939
-62,549
-19% -$2.14M 0.04% 284
2023
Q4 		$11.6M Sell
326,488
-39,950
-11% -$1.27M 0.07% 220
2023
Q3 		$12.5M Buy
366,438
+24,796
+7% +$943K 0.08% 196
2023
Q2 		$13.7M Buy
341,642
+53,775
+19% +$2.14M 0.08% 168
2023
Q1 		$11.3M Sell
287,867
-51,448
-15% -$1.89M 0.07% 196
2022
Q4 		$10.8M Sell
339,315
-132,107
-28% -$3.98M 0.06% 242
2022
Q3 		$13.4M Buy
471,422
+34,719
+8% +$1.19M 0.07% 206
2022
Q2 		$15.6M Buy
436,703
+10,446
+2% +$422K 0.07% 249
2022
Q1 		$21M Buy
426,257
+143,597
+51% +$7.59M 0.08% 170
2021
Q4 		$15.8M Buy
282,660
+43,784
+18% +$2.41M 0.09% 145
2021
Q3 		$13.9M Buy
238,876
+3,105
+1% +$191K 0.08% 163
2021
Q2 		$14.9M Buy
235,771
+98,913
+72% +$6.52M 0.1% 165
2021
Q1 		$8.73M Buy
136,858
+26,220
+24% +$1.52M 0.08% 174
2020
Q4 		$5.79M Buy
110,638
+55,770
+102% +$2.75M 0.05% 178
2020
Q3 		$2.4M Buy
+54,868
New +$2.43M 0.03% 238
2020
Q2 		– Sell
-7,348
Closed -$285K – 521
2020
Q1 		$285K Buy
+7,348
New +$374K 0.01% 348
2019
Q1 		– Sell
-24,774
Closed -$922K – 518
2018
Q4 		$922K Buy
24,774
+2,789
+13% +$101K 0.01% 341
2018
Q3 		$830K Buy
+21,985
New +$915K 0.01% 240
2018
Q2 		– Sell
-75,346
Closed -$3.79M – 538
2018
Q1 		$3.79M Buy
+75,346
New +$4.44M 0.04% 123
2016
Q4 		– Sell
-4,500
Closed -$267K – 355
2016
Q3 		$267K Sell
4,500
-1,500
-25% -$92.2K ﹤0.01% 280
2016
Q2 		$372K Buy
+6,000
New +$369K ﹤0.01% 309
2015
Q4 		– Sell
-14,000
Closed -$708K – 430
2015
Q3 		$708K Buy
+14,000
New +$746K 0.01% 272

Other funds holding XRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Bridgewater Associates's XRAY Position: Q1 2026 in Review

Bridgewater Associates sold out of Dentsply Sirona (XRAY) in Q1 2026, closing a stake of 476,608 shares — an estimated $5.45M sold.

Bridgewater Associates first reported a position in XRAY in Q3 2015 and held it in 28 quarters. The position peaked at $21M in Q1 2022. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Bridgewater Associates reported no remaining Dentsply Sirona position as of Q1 2026 after selling out during the quarter.
  • Bridgewater Associates sold 476,608 Dentsply Sirona shares in Q1 2026, an estimated $5.45M.
  • Bridgewater Associates first reported a position in Dentsply Sirona in Q3 2015 and held it in 28 quarters.
  • Bridgewater Associates's Dentsply Sirona position peaked at $21M in Q1 2022.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.